Probelte Pharma S.L.

Address
Calle Antonio Belmonte Abellan 7

Sponsor Overview

assignment
5
sponsored trials
science
9
molecules
location_city
33
research centres
public
2
countries
person_search
45
investigators

Specializations

Allergen Immunotherapy

Probelte Pharma S.L. focuses on allergen immunotherapy for allergic rhinoconjunctivitis, with research centered on grass pollen and house dust mite sensitisation. Its clinical programme includes subcutaneous immunotherapy approaches for patients with respiratory allergy symptoms linked to environmental allergens.

  • Grass pollen allergy
  • House dust mite allergy
  • Allergic rhinoconjunctivitis

The sponsor’s trials also address patients with allergic rhinoconjunctivitis associated with asthma, reflecting interest in upper and lower airway allergic disease.

Respiratory Allergy

Clinical research activity includes treatment of allergic rhinitis and allergic conjunctivitis caused by inhaled allergens, with emphasis on symptom control in seasonal and perennial disease. The studies are designed around patients affected by exposure to pollen grasses and indoor allergens.

  • Allergic rhinitis
  • Allergic conjunctivitis
  • Environmental allergen exposure

This area includes evaluation of immunotherapy in individuals with persistent nasal and ocular allergy symptoms, supporting research in common respiratory allergy conditions.

Polymerized Allergen Extracts

The sponsor investigates polymerized allergen extracts as therapeutic tools in allergy care, particularly formulations derived from grass pollen mixtures and house dust mite mixtures. These studies reflect a strong interest in allergen-specific treatment strategies.

  • Polymerized grass pollen extract
  • Polymerized house dust mite extract
  • Allergen-specific treatment

Research activity in this field is directed toward improving management of sensitisation-driven disease through targeted immunological intervention.

Sponsored Trials

Data & Insights

science
Molecule Portfolio
Compounds under investigation
2
Exclusive Molecules
out of 9 total (22% not shared with other sponsors)

This sponsor works with 9 molecules, of which 2 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
30%
Return partnership rate
10 of 33 sites collaborated multiple times

This sponsor has worked with 33 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Disorders of Environmental Origin5 trials
    5 other sponsors
  • 2.
    Eye Diseases4 trials
    138 other sponsors

Partnered Research Centres

33 centres
location_city
assignment1
Adax-Med Centrum Alergii i Astmy
Address
ul. Chłopickiego 7/9, 04-314 Warsaw
Learn morearrow_forward
location_city
assignment364
Bellvitge University Hospital
Address
Carrer De La Feixa Llarga S/N, 08907 L'hospitalet De Llobregat
Learn morearrow_forward
location_city
assignment1
Centro Médico Quirónsalud Alicante
Address
Calle Cruz de Piedra, 4, 03015 Alicante
Learn morearrow_forward
location_city
assignment8
Comarch Healthcare S.A.
Address
Ul. Prof. Michala Zyczkowskiego 29 A, 31-864 Krakow
Learn morearrow_forward
location_city
assignment138
Complejo Hospitalario Universitario Insular Materno Infantil
Address
Autovia Del Sur S/n, 35017 Las Palmas de Gran Canaria
Learn morearrow_forward
location_city
assignment2
Febumed Sp. z o.o.
Address
Ul. Bobrowiecka 1, 00-728 Warsaw
Learn morearrow_forward
Page 1 of 6

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Probelte Pharma S.L..

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.